Insider Trading Screener
| Ticker | Issuer Name | Owner Name | Relationship | Transaction Date | Transaction | Shares | Price/Share | Total Value | Shares Owned |
|---|---|---|---|---|---|---|---|---|---|
| HOWL | Werewolf Therapeutics, Inc. | MPM Asset Management Investors BV2014 LLC | 10% Owner | 2025-11-21 | S - D | 64,331 | 0.83 | 53,394.73 | 5,257,105 |
| CBC | Central Bancompany, Inc. | Westhues Daniel Harold | Officer | 2025-11-21 | P - A | 4,200 | 21.00 | 88,200.00 | 95,000 |
| DFDV | DeFi Development Corp. | White Parker | Officer 10% Owner | 2025-11-21 | J - A | 0 | 0.00 | 0.00 | 0 |
| DFDV | DeFi Development Corp. | White Parker | Officer 10% Owner | 2025-11-21 | J - D | 0 | 0.00 | 0.00 | 0 |
| DFDV | DeFi Development Corp. | White Parker | Officer 10% Owner | 2025-11-21 | J - D | 0 | 4.96 | 0.00 | 0 |
| DFDV | DeFi Development Corp. | White Parker | Officer 10% Owner | 2025-11-21 | J - A | 220,397 | 0.00 | 0.00 | 220,397 |
| DFDV | DeFi Development Corp. | White Parker | Officer 10% Owner | 2025-11-21 | J - D | 288,428 | 0.00 | 0.00 | 0 |
| DFDV | DeFi Development Corp. | White Parker | Officer 10% Owner | 2025-11-21 | J - D | 27,104 | 0.00 | 0.00 | 33,384 |
| ARDX | ARDELYX, INC. | Williams Laura A | 2025-11-21 | S - D | 6,426 | 5.54 | 35,580.12 | 359,896 | |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | 2025-11-21 | A - A | 1,903 | 0.00 | 0.00 | 22,215 | |
| NKTR | NEKTAR THERAPEUTICS | Wilson Mark Andrew | 2025-11-21 | A - A | 3,400 | 0.00 | 0.00 | 3,400 | |
| HTH | Hilltop Holdings Inc. | Winges Martin Bradley | 2025-11-21 | A - A | 0 | 0.00 | 0.00 | 0 | |
| (SIRI) | SIRIUS XM HOLDINGS INC. | Witz Jennifer C | Director Officer | 2025-11-21 | A - A | 0 | 0.00 | 0.00 | 0 |
| PLNH | Planet 13 Holdings Inc. | Wren Chris | Officer | 2025-11-21 | S - D | 100,000 | 0.17 | 17,020.00 | 4,515,511 |
| KLC | KinderCare Learning Companies, Inc. | Wyatt John T. | 2025-11-21 | F - D | 2,386 | 4.18 | 9,973.48 | 72,929 | |
| XEL | XCEL ENERGY INC | Long Ryan J. | 2025-11-21 | G - D | 1,265 | 0.00 | 0.00 | 0 | |
| XLO | Xilio Therapeutics, Inc. | Russo Rene | 2025-11-21 | A - A | 2,075,000 | 0.00 | 0.00 | 2,075,000 | |
| XLO | Xilio Therapeutics, Inc. | Russo Rene | 2025-11-21 | D - D | 239,703 | 0.00 | 0.00 | 0 | |
| XLO | Xilio Therapeutics, Inc. | Russo Rene | 2025-11-21 | A - A | 239,703 | 0.00 | 0.00 | 239,703 | |
| XLO | Xilio Therapeutics, Inc. | Russo Rene | 2025-11-21 | D - D | 473,334 | 0.00 | 0.00 | 0 | |
| XLO | Xilio Therapeutics, Inc. | Russo Rene | 2025-11-21 | A - A | 473,334 | 0.00 | 0.00 | 473,334 | |
| XLO | Xilio Therapeutics, Inc. | Russo Rene | 2025-11-21 | D - D | 135,134 | 0.00 | 0.00 | 0 | |
| XLO | Xilio Therapeutics, Inc. | Russo Rene | 2025-11-21 | A - A | 135,134 | 0.00 | 0.00 | 135,134 | |
| XLO | Xilio Therapeutics, Inc. | Russo Rene | 2025-11-21 | D - D | 50,041 | 0.00 | 0.00 | 0 | |
| XLO | Xilio Therapeutics, Inc. | Russo Rene | 2025-11-21 | A - A | 50,041 | 0.00 | 0.00 | 50,041 |